|
Name |
Pseudocercone B
|
Molecular Formula | C18H16O7 | |
IUPAC Name* |
6-acetyl-2',4,4'-trimethoxyspiro[2-benzofuran-3,6'-cyclohexa-2,4-diene]-1,1'-dione
|
|
SMILES |
COC1=CC2(OC(=O)c3cc(C(C)=O)cc(OC)c32)C(=O)C(OC)=C1
|
|
InChI |
InChI=1S/C18H16O7/c1-9(19)10-5-12-15(13(6-10)23-3)18(25-17(12)21)8-11(22-2)7-14(24-4)16(18)20/h5-8H,1-4H3/t18-/m0/s1
|
|
InChIKey |
QBEYKXLAHKRZRD-SFHVURJKSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 344.32 | ALogp: | 1.9 |
HBD: | 0 | HBA: | 7 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 88.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 25 | QED Weighted: | 0.612 |
Caco-2 Permeability: | -4.803 | MDCK Permeability: | 0.00003600 |
Pgp-inhibitor: | 0.996 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.1 | 20% Bioavailability (F20%): | 1 |
30% Bioavailability (F30%): | 0.989 |
Blood-Brain-Barrier Penetration (BBB): | 0.902 | Plasma Protein Binding (PPB): | 78.13% |
Volume Distribution (VD): | 1.015 | Fu: | 18.43% |
CYP1A2-inhibitor: | 0.383 | CYP1A2-substrate: | 0.919 |
CYP2C19-inhibitor: | 0.925 | CYP2C19-substrate: | 0.877 |
CYP2C9-inhibitor: | 0.745 | CYP2C9-substrate: | 0.089 |
CYP2D6-inhibitor: | 0.022 | CYP2D6-substrate: | 0.183 |
CYP3A4-inhibitor: | 0.687 | CYP3A4-substrate: | 0.829 |
Clearance (CL): | 3.818 | Half-life (T1/2): | 0.796 |
hERG Blockers: | 0.08 | Human Hepatotoxicity (H-HT): | 0.967 |
Drug-inuced Liver Injury (DILI): | 0.864 | AMES Toxicity: | 0.347 |
Rat Oral Acute Toxicity: | 0.616 | Maximum Recommended Daily Dose: | 0.862 |
Skin Sensitization: | 0.914 | Carcinogencity: | 0.127 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.02 |
Respiratory Toxicity: | 0.547 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005981 | 0.417 | D0C1SF | 0.357 | ||||
ENC003227 | 0.409 | D09DHY | 0.321 | ||||
ENC002319 | 0.387 | D06GCK | 0.292 | ||||
ENC002478 | 0.379 | D02LZB | 0.288 | ||||
ENC002579 | 0.379 | D0N1FS | 0.282 | ||||
ENC001494 | 0.371 | D0A8FB | 0.281 | ||||
ENC003355 | 0.363 | D0NJ3V | 0.264 | ||||
ENC003213 | 0.360 | D0F7CS | 0.261 | ||||
ENC001073 | 0.357 | D07ESC | 0.260 | ||||
ENC002837 | 0.354 | D0AO5H | 0.260 |